Pregnancy Management In Cml Patients: To Treat Or Not To Treat? Report Of 224 Outcomes Of The European Leukemia Net (Eln) Database

Pregnancy in CML patients (pts) is becoming a reality due to the increase in information from published cases or larger multicentric database (GIMEMA and ELN). Interferon (IFN) has been used during pregnancy, but little is known about the use of tyrosine kinase inhibitors (TKIs), which should be stopped early due to their teratogenic effects.